Mylan - 31 Year Stock Price History | MYL

Historical daily stock prices for Mylan since 1987 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Mylan (MYL) as of July 13, 2018 is 36.58.
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.011B $11.908B
Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as Mylan Inc., is based in Canonsburg, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $60.065B 10.56
Teva Pharmaceutical Industries (TEVA) Israel $23.683B 6.19
Dr Reddy's Laboratories (RDY) India $5.512B 32.91
Supernus Pharmaceuticals (SUPN) United States $2.678B 33.57
Akorn (AKRX) United States $2.243B 11.12
AxoGen (AXGN) United States $1.823B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.799B 3.03
Assembly Biosciences (ASMB) United States $0.856B 0.00
Homology Medicines (FIXX) United States $0.815B 0.00
CymaBay Therapeutics (CBAY) United States $0.776B 0.00
Amphastar Pharmaceuticals (AMPH) United States $0.771B 71.87
Adamas Pharmaceuticals (ADMS) United States $0.730B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.613B 0.00
Voyager Therapeutics (VYGR) United States $0.591B 0.00
Corium (CORI) United States $0.290B 0.00
Teligent (TLGT) United States $0.205B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.141B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Versartis (VSAR) United States $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.062B 0.00
Aevi Genomic Medicine (GNMX) United States $0.058B 0.00
Evoke Pharma (EVOK) United States $0.045B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.029B 0.00
Agile Therapeutics (AGRX) United States $0.018B 0.00
Acasti Pharma (ACST) Canada $0.015B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00